PHILADELPHIA, Aug. 5, 2019 /PRNewswire/ -- The number of people struggling with opioid addiction in Pennsylvania has long been higher than the national average. In fact, the state ranks third for drug overdose deaths, according to the CDC.There simply aren't enough treatment beds in the area to provide those with drug or alcoh

DENVER, Aug. 5, 2019 /PRNewswire/ -- BLOCK21 Fitness, a new workout class program centered around cardio hip-hop fitness, opened its new studio today at 930 N.

NEW YORK, Aug. 5, 2019 /PRNewswire/ -- Neurotrope, Inc. (Nasdaq: NTRP), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, including Alzheimer's disease (AD), today provided an update on clinical and corporate developments, including its ongoing confirmatory Phase 2 study of Bryostatin-1 in moderate to severe AD, an

BEDFORD, Mass., Aug. 5, 2019 /PRNewswire/ -- Instrumentation Laboratory (IL) today announced the unveiling of their latest innovation, the GEM Premier ChemSTAT in vitro diagnostic (IVD) analyzer with Intelligent Quality Management (iQM) at the American Association for Clinical Chemistry (AACC) Annual Meeting in

PHOENIX, Aug. 5, 2019 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. (OTC: CELZ), a leading clinical-stage biotechnology company focu

SAN DIEGO, Aug. 5, 2019 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced financial results for the three and six months ended June 30, 2019

RALEIGH, N.C. and TAMPA, Fla., Aug. 5, 2019 /PRNewswire/ -- WellCare Health Plans, Inc. (NYSE: WCG) has named Eugenie M. Komives, M.D., FAAFP, chief medical officer for North Carolina. Dr. Komives will oversee the plan's medical strategy and clinical direction of healthc

NORTH CHICAGO, Ill., Aug. 5, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, in cooperation with Neurocrine Biosciences, Inc. (NASDAQ: NBIX), today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for elagolix, an investigational, oral gonadotropin-releasing hormone (

WASHINGTON, Aug. 5, 2019 /PRNewswire/ -- In a joint announcement today, the leaders of PATH and the Telemedicine and Telehealth Service Provider Summit (SPS) have agreed to have SPS formally incorporated into PATH.  The agreement brings to PATH a highly rated and expanding conference that further advances telehealth partnerships."The Arizona Telemedicine

PALO ALTO, Calif., Aug. 5, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced that the newly proposed tariffs by the U.S. on the remaining $300 billion of Chinese imports should have no material impact to the company.Last Thursday, the U.S. announced plans to impose a 10 percent tax on $300 billion